2022-08-11T12:25:59-05:00 2021-09-30 ERNST & YOUNG US LLP ONE MANHATTAN WEST NEW YORK NY 10001 990 2020-10-01 043320640 Dana-FarberMass General Brigham Cancer Care INC % MELISSA CHAMMAS DANA 6176323000 450 Brookline Ave BP418 Boston MA 02215 SALLY MASON BOEMER TREASURER 6176323000 2022-08-10 true SALLY MASON BOEMER 999009999 NICOLE SOKOLOWSKI P01683199 2127733000 2022-08-01 3 2020 2022-09-23 18:48:47Z RAMESH A SHIVDASANI MD 450 Brookline Ave BP418 Boston MA 02215 95186368 false X www.cancercare.harvard.edu X 1996 MA COORDINATION OF ONCOLOGY CLINICAL RESEARCH, EDUCATION, AND PROGRAMS ACROSS DANA-FARBER, MASSACHUSETTS GENERAL HOSPITAL, AND BRIGHAM AND WOMEN'S HOSPITAL. 6 0 0 0 0 0 0 0 91080884 95108873 52858 77495 0 0 91133742 95186368 0 0 0 0 643926 600518 0 0 0 90558872 95418661 91202798 96019179 -69056 -832811 35112904 42647489 25069398 30899874 10043506 11747615 COORDINATION OF ONCOLOGY CLINICAL RESEARCH, EDUCATION, AND PROGRAMS ACROSS DANA-FARBER, MASSACHUSETTS GENERAL HOSPITAL, AND BRIGHAM AND WOMEN'S HOSPITAL. false false 95108873 0 95108873 CLINICAL TRIAL STUDIES AND RESEARCH RELATED TO INVESTIGATING NEW MEDICATIONS AND METHODS OF TREATMENT OF CANCER, WITH HOPE OF FINDING A CURE. 373630 0 0 EDUCATIONAL PROGRAMS FOR CLINICIANS AND RESEARCHERS WITH A FOCUS ON THE DF/MGH HEMATOLOGY ONCOLOGY FELLOWSHIP PROGRAM. 246113 0 0 DEVELOPMENT OF CLINICAL GUIDELINES, PROTOCOLS, AND STANDARDS OF CARE FOR THE TREATMENT OF CANCER, AS WELL AS ESTABLISHING PRIORITIES FOR RESEARCH. 0 0 0 95728616 true false false false false false false false false false false false false true true true true false false false false false false false false false false false false true false false false false false false false false false false false false false true false false false true 0 0 true 0 false false false false false false false false false false false false X 6 0 false false false false true true true true true false false true true true true true true true false false MA X MELISSA CHAMMAS 6176323000 C/O DFCI 450 BROOKLINE AVE BP418 Boston MA 02215 X Laurie H Glimcher MD Former Officer 0.0 50.0 X 0 1724225 302393 Sally Mason Boemer Treasurer 1.0 49.0 X 0 1163196 61781 Edward J Benz JR MD Former Officer 0.0 50.0 X 0 1133382 57427 David P Ryan MD Trustee 1.0 49.0 X 0 1035128 137401 Ravi I Thadhani MD MPH Trustee 1.0 49.0 X 0 1098765 63621 Joseph Loscalzo MD PhD Trustee 1.0 49.0 X 0 785283 64545 Bruce Johnson MD Trustee 1.0 49.0 X 0 679531 61539 Richard S Boskey ESQ Former Officer 0.0 49.0 X 0 652019 68313 Jeffrey Meyerhardt MD Trustee 1.0 49.0 X 0 428226 73601 Ramesh A Shivdasani MD Trustee and President 2.0 48.0 X X 0 449050 50051 Ellen Farwell ESQ Clerk (End 06/10/21) 1.0 49.0 X 0 180376 12355 John Ryan Esq Clerk (As of 7/19/21) 1.0 49.0 X 0 80838 2016 0 9410019 955043 0 true true false Dana-Farber Cancer Institute Inc 450 Brookline Ave BP418 BOSTON MA 02215 Research Services 53285589 Massachusetts General Hospital 399 REVOLUTION DRIVE SUITE 645 SOMERVILLE MA 02145 Research Services 31593165 BRIGHAM AND WOMEN'S HOSPITAL 399 REVOLUTION DRIVE SUITE 645 SOMERVILLE MA 02145 Research Services 3831784 BETH ISRAEL DEACONESS MEDICAL CENTE 110 Francis St BOSTON MA 02115 Research Services 3101614 MASS GENERAL BRIGHAM INC 399 Revolution Drive SUITE 645 SOMERVILLE MA 02145 Information SYSTEMS 167718 9 0 CLINICAL TRIALS/RESEARCH 621500 95108873 95108873 95108873 77495 77495 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 95186368 95108873 77495 X 0 0 0 0 0 0 484289 484289 0 116229 116229 0 0 0 29000 29000 0 0 0 95244274 95244274 0 0 0 0 144800 144800 0 0 0 0 0 0 0 0 0 MISCELLANEOUS 587 53 534 96019179 95728616 290563 0 24768225 27353102 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9989 9989 0 0 9236056 11850471 0 0 0 0 0 0 1098634 3433927 35112904 42647489 28000 29641 0 0 0 0 0 0 0 0 0 0 0 0 0 0 25041398 30870233 25069398 30899874 X 10043506 11747615 0 0 10043506 11747615 35112904 42647489 -832811 2536920 X false true X true false X X 3 DANA-FARBER CANCER INSTITUTE INC 042263040 7 true 0 0 THE GENERAL HOSPITAL CORPORATION 042697983 3 true 0 0 BRIGHAM & WOMEN'S HOSPITAL 042312909 3 true 0 0 3 0 0 true false false false false false false false false false false false false false false false true Schedule A, Part I, Line 12G Dana-Farber/Mass General Brigham Cancer Care, Inc. ("DF/MGBCC, INC.") SUPPORTS ONLY DANA-FARBER CANCER INSTITUTE, INC., THE GENERAL HOSPITAL CORPORATION, AND BRIGHAM & WOMEN'S HOSPITAL. DF/MGBCC, INC. DOES NOT PROVIDE DIRECT MONETARY SUPPORT TO THESE ENTITIES. IN THIS SITUATION, DF/MGBCC, INC. PROVIDES SUPPORT FOR EDUCATIONAL PROGRAMS, CLINICAL TRIAL STUDIES, AND RESEARCH TO THE SUPPORTED ORGANIZATIONS. Schedule A, Part IV, Section B, Lines 1 & 2 PURSUANT TO DF/MGBCC, INC.'S ARTICLES OF ORGANIZATION, IT "IS ORGANIZED AND SHALL BE OPERATED EXCLUSIVELY FOR THE BENEFIT OF THE BRIGHAM AND WOMEN'S HOSPITAL, INC. ('BWH'), DANA-FARBER CANCER INSTITUTE, INC. ('DFCI'), AND THE GENERAL HOSPITAL CORPORATION ('MGH')". BWH, DFCI, AND MGH ARE PUBLICLY SUPPORTED ORGANIZATIONS WITHIN THE MEANING OF 26 USC 509(A). UNDER DF/MGBCC, INC.'S BY-LAWS, DFCI AND MASS GENERAL BRIGHAM, INC., AS THE TWO CORPORATE MEMBERS OF DF/MGBCC, INC., HAVE THE POWER TO APPOINT AN EQUAL PROPORTION OF THE MEMBERS OF DF/MGBCC, INC.'S BOARD OF TRUSTEES. DF/MGBCC, INC. BENEFITS THE BWH, DFCI, AND MGH BY PERFORMING SERVICES IN CONNECTION WITH EDUCATION PROGRAMS, CLINICAL TRIALS, AND OTHER RESEARCH PROGRAMS FOR THE HOSPITALS. IN THIS WAY, DFCI AND MGB'S PURPOSES OF PROVIDING EXCELLENT MEDICAL CARE AND ENGAGING IN CRITICAL CANCER RESEARCH ARE SERVED BY THE SUPPORT THAT DF/MGBCC, INC. PROVIDES TO THE HOSPITALS. UNDER 26 CFR 1.509(A)-4(G)(II), DF/MGBCC, INC. IS CONSIDERED TO BE "CONTROLLED BY" DFCI AND MGB WITHIN THE MEANING OF 26 USC 509(A)(3)(B), EVEN THOUGH DF/MGBCC, INC. IS "OPERATED FOR THE BENEFIT OF" THE HOSPITALS WITHIN THE MEANING OF 509(A)(3)(A). DUE FROM AFFILIATES 3433927 3433927 0 RESEARCH ADVANCES 30870233 30870233 X 95186368 95186368 95186368 96019179 96019179 96019179 Schedule D, Part X, Line 2 The Corporation is a not-for-profit corporation and is tax-exempt under Section 501(c)(3) of the Internal Revenue Code. Tax-exempt organizations could be required to record an obligation for income taxes as the result of a tax position they have historically taken on various tax exposure items including unrelated business income or tax status. Under guidance issued by the Financial Accounting Standards Board (FASB), assets and liabilities are established for uncertain tax positions taken or positions expected to be taken in income tax returns when such positions are judged to not meet the "more-likely-than-not" threshold, based upon the technical merits of the position. The Corporation has evaluated the position taken on its filed tax returns. The Corporation has concluded no uncertain income tax positions exist at September 30, 2021. false true false false false false false false false Laurie H Glimcher MD Former Officer 0 1220120 0 422902 0 81203 0 285781 0 16612 0 2026618 0 0 Sally Mason Boemer Treasurer 0 805000 0 284100 0 74096 0 31350 0 30431 0 1224977 0 0 Edward J Benz JR MD Former Officer 0 565636 0 400 0 567346 0 40140 0 17287 0 1190809 0 0 David P Ryan MD Trustee 0 733844 0 9585 0 291699 0 113718 0 23683 0 1172529 0 0 Ravi I Thadhani MD MPH Trustee 0 799750 0 221823 0 77192 0 31350 0 32271 0 1162386 0 0 Joseph Loscalzo MD PhD Trustee 0 686221 0 87871 0 11191 0 38718 0 25827 0 849828 0 0 Bruce Johnson MD Trustee 0 546586 0 104249 0 28696 0 38623 0 22916 0 741070 0 0 Richard S Boskey ESQ Former Officer 0 536204 0 93760 0 22055 0 40140 0 28173 0 720332 0 0 Jeffrey Meyerhardt MD Trustee 0 400241 0 20326 0 7659 0 38215 0 35386 0 501827 0 0 Ramesh A Shivdasani MD Trustee and President 0 442499 0 400 0 6151 0 40140 0 9911 0 499101 0 0 Ellen Farwell ESQ Clerk (End 06/10/21) 0 179704 0 400 0 272 0 7956 0 4399 0 192731 0 0 SCHEDULE J THE DEFERRED COMP AWARDS/OTHER BENEFITS FIGURE MAY INCLUDE AWARDS OF DEFERRED COMPENSATION, THE VALUE OF OTHER EMPLOYEE TAXABLE BENEFITS IN WHICH THE EMPLOYEE PARTICIPATES, SUCH AS LIFE INSURANCES, DEFERRED COMPENSATION PLANS, TUITION BENEFIT PLANS, HOUSING ALLOWANCES, AND THE VALUE OF NON-TAXABLE EMPLOYEE BENEFIT PLANS SUCH AS PENSION, GROUP HEALTH, LIFE, AND DISABILITY WHICH THE EMPLOYER PROVIDES TO EMPLOYEES ON A NON-DISCRIMINATORY BASIS AS REQUIRED BY THE IRS. NONE OF THE OFFICERS OR EMPLOYEES RECEIVE EXPENSE ACCOUNTS OR ALLOWANCES WHICH CONSTITUTE TAXABLE COMPENSATION. THE CORPORATION HAS AN "ACCOUNTABLE PLAN" WHICH PAYS FOR OR REIMBURSES EXPENSES ONLY IF THEY ARE "ORDINARY, NECESSARY, AND REASONABLE" EXPENSES "INCURRED FOR A BONA FIDE BUSINESS PURPOSE." THE CORPORATION CARRIES LIABILITY INSURANCE THAT COVERS ITS TRUSTEES AND OFFICERS. THIS INSURANCE COVERAGE PROVIDES AN INCIDENTAL BENEFIT TO THE COVERED INDIVIDUALS. SCHEDULE J, PART I, LINE 3 PROCESS FOR DETERMINING COMPENSATION OF PRESIDENT: FOR FY21, THE COMPENSATION COMMITTEE OF THE BOARD OF TRUSTEES OF DFCI REVIEWS THE PERFORMANCE OF THE PRESIDENT AND MAKES A RECOMMENDATION REGARDING COMPENSATION TO DFCI'S EXECUTIVE COMMITTEE, WHICH THEN APPROVES SUCH COMPENSATION. SCHEDULE J, PART I, LINE 4B THE FOLLOWING INDIVIDUALS PARTICIPATE IN 457(F) PLANS ESTABLISHED BY DFCI; TAXABLE AMOUNTS ARE INCLUDED IN REPORTABLE COMPENSATION IN SCHEDULE J, PART II, COLUMN (B)(III): LAURIE H. GLIMCHER, MD $ 66,725 EDWARD J. BENZ JR., MD $ 554,876 BRUCE JOHNSON, MD $ 10,339 Richard S. Boskey, ESQ $ 9,608 RAMESH A. SHIVDASANI, MD $ 1,337 Form 990, Part VI, SECTION A, Line 6 MEMBERS OR STOCKHOLDERS DANA-FARBER CANCER INSTITUTE, INC. ("DFCI") AND Mass General Brigham, Inc. ("MGB") ARE THE MEMBERS OF DANA-FARBER/MASS GENERAL BRIGHAM CANCER CARE, INC. ("DF/MGBCC, Inc.") Form 990, Part VI, SECTION A, Lines 7A & 7B POWER TO ELECT OR APPOINT GOVERNING BODY THE MEMBERS HAVE THE AUTHORITY TO ELECT OR APPOINT THE GOVERNING BODY OF DF/MGBCC, Inc. CERTAIN GOVERNANCE DECISIONS RELATING TO SIGNIFICANT TRANSACTIONS, AMENDMENTS TO THE GOVERNING DOCUMENTS OF THE CORPORATION AND THE DISSOLUTION OF THE CORPORATION ARE RESERVED TO THE MEMBERS. FORM 990, PART VI, SECTION B, LINE 11B PROCESS USED TO REVIEW THE FORM 990 THE DANA-FARBER CANCER INSTITUTE TAX DEPARTMENT PROVIDES ALL FINANCIAL ANALYSIS AND OTHER INFORMATION TO BE INCLUDED ON THE TAX RETURN TO ITS EXTERNAL TAX PREPARER, ERNST & YOUNG LLP, WHICH PREPARES THE DRAFT RETURN. THE DRAFT RETURN IS REVIEWED BY THE TREASURER AND THE BOARD OF TRUSTEES. A FINAL VERSION OF THE FORM IS MADE AVAILABLE TO THE BOARD BEFORE FILING WITH THE IRS. Form 990, Part VI, SECTION B, Line 12C MONITORING & ENFORCEMENT OF CONFLICT OF INTEREST POLICY DF/MGBCC, INC. HAS A WRITTEN CONFLICT OF INTEREST POLICY THAT IS CONSISTENT WITH THE IRS SAMPLE CONFLICT OF INTEREST POLICY. PER THE DF/MGBCC, INC. CONFLICT OF INTEREST POLICY, IN ORDER TO AVOID A CONFLICT OF INTEREST OR AN APPEARANCE OF A CONFLICT OF INTEREST A TRUSTEE SHOULD NOT PARTICIPATE IN A VOTE ON A TRANSACTION IN WHICH THE TRUSTEE OR FAMILY MEMBER HAS A FINANCIAL INTEREST AND SHOULD DISCLOSE ANY POTENTIAL CONFLICT BEFORE DF/MGBCC, INC. ACTS ON THE TRANSACTION. IF A DISCLOSURE WAS MADE, THE BOARD OF TRUSTEES WOULD INVESTIGATE ALTERNATIVES TO THE PROPOSED TRANSACTION AND DETERMINE WHETHER A MORE ADVANTAGEOUS TRANSACTION THAT WOULD NOT GIVE RISE TO A CONFLICT WOULD BE REASONABLY ATTAINABLE. IF SUCH A TRANSACTION IS NOT ATTAINABLE, A TRANSACTION WITH A TRUSTEE, A MEMBER OF HIS OR HER FAMILY, OR AN ENTITY WITH WHICH ONE OR MORE OF THEM HAS A MATERIAL INTEREST, MAY BE APPROVED BY THE MAJORITY VOTE OF THE DISINTERESTED TRUSTEES. Form 990, Part VI, SECTION B, Line 15A PROCESS FOR DETERMINING COMPENSATION OF PRESIDENT FOR FY21, THE COMPENSATION COMMITTEE OF THE BOARD OF TRUSTEES OF DFCI REVIEWS THE PERFORMANCE OF THE PRESIDENT AND MAKES A RECOMMENDATION REGARDING COMPENSATION TO DFCI'S EXECUTIVE COMMITTEE, WHICH THEN APPROVES SUCH COMPENSATION. Form 990, Part VI, SECTION C, Line 19 AVAILABILITY OF GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND FINANCIAL STATEMENTS GOVERNING DOCUMENTS: WE CURRENTLY PROVIDE THE GOVERNING DOCUMENTS UPON REQUEST. THE ARTICLES OF ORGANIZATION ARE ALSO AVAILABLE TO THE PUBLIC ON THE SECRETARY OF THE COMMONWEALTH'S WEBSITE. CONFLICT OF INTEREST POLICY: DF/MGBCC, INC.'S CONFLICT OF INTEREST POLICY IS AVAILABLE UPON REQUEST. FINANCIAL STATEMENTS: AUDITED FINANCIAL STATEMENTS ARE PROVIDED UPON REQUEST. FORM 990, PART VII, SECTION A, LINE 1A THE INDIVIDUALS WHO HAVE COMPENSATION FROM RELATED ORGANIZATIONS IN COLUMN E SPEND THE REMAINDER OF THEIR FULL-TIME HOURS WORKING FOR DANA-FARBER CANCER INSTITUTE, INC. OR MASS GENERAL BRIGHAM, INC. AND ITS AFFILIATES. FORM 990 PART IX LINE 11G DESCRIPTION:INST. SUPPORT TOTAL FEES:95108874 FORM 990 PART IX LINE 11G DESCRIPTION:MEDICAL FEES TOTAL FEES:135400 Dana-Farber Cancer Institute Inc 450 BROOKLINE AVENUE BP418 Boston MA 02215 042603040 Cancer Care MA 501(c)(3) 7 NA false The General Hospital Corporation 55 FRUIT STREET BOSTON MA 02114 042697983 Hospital MA 501(c)(3) 3 NA false The Brigham & Women's Hospital 75 FRANCIS STREET BOSTON MA 02115 042312909 Hospital MA 501(c)(3) 3 NA false false false false false false false false false false false false false true false false false false false false DANA-FARBER CANCER INSTITUTE INC M 52323978 COST THE GENERAL HOSPITAL CORPORATION M 34458901 COST THE BRIGHAM AND WOMEN'S HOSPITAL M 3395786 COST